Showing results (11-20 of 33) with videos related to
Sort By:
Pageof 4
Immunopharmacology and Immunotoxicology|August 15, 2012
Anti-gastritis and wound healing effects of Momordicae Semen extract and its active componentKiwon Jung, Young-Won Chin, Yoon Hee Chung, et al.Molecular and Cellular Biology|January 21, 2016
MicroRNA 211 Functions as a Metabolic Switch in Human Melanoma CellsJoseph Mazar, Feng Qi, Bongyong Lee, et al.Acta Neuropathologica Communications|February 25, 2022
Medulloblastoma cerebrospinal fluid reveals metabolites and lipids indicative of hypoxia and cancer-specific RNAsBongyong Lee, Iqbal Mahmud, Rudramani Pokhrel, et al.Clinical Therapeutics|August 22, 2009
Influence of alcohol on the hemodynamic effects and pharmacokinetic properties of mirodenafil: a single-dose, randomized-sequence, open-label, crossover study in healthy male volunteers in KoreaBo-Hyung Kim, SoJeong Yi, JaeWoo Kim, et al.Neuro-Oncology Advances|October 21, 2022
The long non-coding RNA <i>SPRIGHTLY</i> and its binding partner PTBP1 regulate exon 5 skipping of <i>SMYD3</i> transcripts in group 4 medulloblastomasBongyong Lee, Keisuke Katsushima, Rudramani Pokhrel, et al.Clinical Therapeutics|August 28, 2012
Assessment of the effect of mirodenafil on the hemodynamics of healthy male Korean volunteers administered tamsulosin: a randomized, double-blind, placebo-controlled, 2-period crossover studyNamyi Gu, JaeWoo Kim, Kyoung Soo Lim, et al.European Journal of Medicinal Chemistry|March 5, 2026
Discovery of triazolyl azabicyclo[3.1.0]hexane derivative as an autotaxin inhibitors for the treatment of pulmonary fibrosisJiho Kim, Jiawei Sun, Young Ah Shin, et al.The Journal of Investigative Dermatology|February 2, 2016
The Long Noncoding RNA SPRIGHTLY Regulates Cell Proliferation in Primary Human MelanocytesWei Zhao, Joseph Mazar, Bongyong Lee, et al.Journal of Pharmaceutical and Biomedical Analysis|August 11, 2007
Development of LC/MS/MS assay for the determination of 5-ethyl-2-{5-[4-(2-hydroxyethyl)piperazine-1-sulfonyl]-2-propoxyphenyl}-7-propyl-3,5-dihydropyrrolo[3,2-d]pyrimidin-4-one (SK3530) in human plasma: application to a clinical pharmacokinetic studyBeom Soo Shin, Seul Ki Hu, John Kim, et al.Bioorganic Chemistry|April 8, 2025
Targeting Autotaxin with imidazole- and Triazolyl-based inhibitors: Biological insights from in vitro and in vivo studies in pulmonary fibrosisMisu Kim, Minh Thanh La, Young Ah Shin, et al.Pageof 4